These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 29053938)

  • 1. Development of a nanogel-based nasal vaccine as a novel antigen delivery system.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Expert Rev Vaccines; 2017 Dec; 16(12):1231-1240. PubMed ID: 29053938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Hum Vaccin Immunother; 2018; 14(9):2189-2193. PubMed ID: 29624474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanogel-based antigen-delivery system for nasal vaccines.
    Yuki Y; Nochi T; Kong IG; Takahashi H; Sawada S; Akiyoshi K; Kiyono H
    Biotechnol Genet Eng Rev; 2013; 29():61-72. PubMed ID: 24568253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodistribution assessment of cationic pullulan nanogel, a nasal vaccine delivery system, in mice and non-human primates.
    Yuki Y; Harada N; Sawada SI; Uchida Y; Nakahashi-Ouchida R; Mori H; Yamanoue T; Machita T; Kanazawa M; Fukumoto D; Ohba H; Miyazaki T; Akiyoshi K; Fujihashi K; Kiyono H
    Vaccine; 2023 Jul; 41(34):4941-4949. PubMed ID: 37385890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanogel-based delivery system enhances PGE2 effects on bone formation.
    Kato N; Hasegawa U; Morimoto N; Saita Y; Nakashima K; Ezura Y; Kurosawa H; Akiyoshi K; Noda M
    J Cell Biochem; 2007 Aug; 101(5):1063-70. PubMed ID: 17520665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-assembled pH-sensitive cholesteryl pullulan nanogel as a protein delivery vehicle.
    Morimoto N; Hirano S; Takahashi H; Loethen S; Thompson DH; Akiyoshi K
    Biomacromolecules; 2013 Jan; 14(1):56-63. PubMed ID: 23215439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-assembled polysaccharide nanogel delivery system for overcoming tumor immune resistance.
    Muraoka D; Harada N; Shiku H; Akiyoshi K
    J Control Release; 2022 Jul; 347():175-182. PubMed ID: 35526613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current advances in self-assembled nanogel delivery systems for immunotherapy.
    Tahara Y; Akiyoshi K
    Adv Drug Deliv Rev; 2015 Dec; 95():65-76. PubMed ID: 26482187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of nanogel-based vaccines.
    Hernández-Adame L; Angulo C; García-Silva I; Palestino G; Rosales-Mendoza S
    Expert Rev Vaccines; 2019 Sep; 18(9):951-968. PubMed ID: 31487213
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanogel vaccines targeting dendritic cells: contributions of the surface decoration and vaccine cargo on cell targeting and activation.
    Thomann-Harwood LJ; Kaeuper P; Rossi N; Milona P; Herrmann B; McCullough KC
    J Control Release; 2013 Mar; 166(2):95-105. PubMed ID: 23220107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses.
    Li P; Luo Z; Liu P; Gao N; Zhang Y; Pan H; Liu L; Wang C; Cai L; Ma Y
    J Control Release; 2013 Jun; 168(3):271-9. PubMed ID: 23562637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanogel-Mediated antigen delivery: Biocompatibility, immunogenicity, and potential for tailored vaccine design across species.
    Laura Soriano Pérez M; Montironi I; Alejandro Funes J; Margineda C; Campra N; Noelia Cariddi L; José Garrido J; Molina M; Alustiza F
    Vaccine; 2024 Jun; 42(17):3721-3732. PubMed ID: 38719694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
    Azegami T; Yuki Y; Nakahashi R; Itoh H; Kiyono H
    Mol Immunol; 2018 Jun; 98():19-24. PubMed ID: 29096936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines.
    Nochi T; Yuki Y; Takahashi H; Sawada S; Mejima M; Kohda T; Harada N; Kong IG; Sato A; Kataoka N; Tokuhara D; Kurokawa S; Takahashi Y; Tsukada H; Kozaki S; Akiyoshi K; Kiyono H
    Nat Mater; 2010 Jul; 9(7):572-8. PubMed ID: 20562880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cancer vaccination by transdermal delivery of antigen peptide-loaded nanogels via iontophoresis.
    Toyoda M; Hama S; Ikeda Y; Nagasaki Y; Kogure K
    Int J Pharm; 2015 Apr; 483(1-2):110-4. PubMed ID: 25681719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein antigen conjugated with cholesteryl amino-pullulan nanogel shows delayed degradation in dendritic cells and augmented immunogenicity.
    Long W; Kunitake S; Sawada SI; Akiyoshi K; Tsubata T
    Vaccine; 2021 Dec; 39(52):7526-7530. PubMed ID: 34852944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. H9N2 influenza whole inactivated virus combined with polyethyleneimine strongly enhances mucosal and systemic immunity after intranasal immunization in mice.
    Qin T; Yin Y; Huang L; Yu Q; Yang Q
    Clin Vaccine Immunol; 2015 Apr; 22(4):421-9. PubMed ID: 25673304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2-specific T-cell immune responses in patients vaccinated with truncated HER2 protein complexed with nanogels of cholesteryl pullulan.
    Kitano S; Kageyama S; Nagata Y; Miyahara Y; Hiasa A; Naota H; Okumura S; Imai H; Shiraishi T; Masuya M; Nishikawa M; Sunamoto J; Akiyoshi K; Kanematsu T; Scott AM; Murphy R; Hoffman EW; Old LJ; Shiku H
    Clin Cancer Res; 2006 Dec; 12(24):7397-405. PubMed ID: 17189412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and Efficacy of Nanogels Formulations for Intranasal Administration.
    Aderibigbe BA; Naki T
    Molecules; 2018 May; 23(6):. PubMed ID: 29789506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.